HOME >> MEDICINE >> NEWS
University Of Pittsburgh Cancer Institute Defines First Immunologic Markers Of Interferon Effectiveness Against Melanoma

PITTSBURGH, May 17 -- For the first time, investigators have correlated the use of interferon alfa 2b (IFNa2b) with specific immune responses in patients treated with high doses of this agent to prevent the recurrence of melanoma. These findings, part of a landmark multi-center study based at the University of Pittsburgh Cancer Institute (UPCI), begin to account for the impact of IFNa2b on relapse-free survival among study patients. The results shed light on how this biological therapy works and provide signposts that could one day help clinicians pinpoint which patients will benefit from therapy, according to the investigators, who are presenting their preliminary findings Monday, May 17, at the annual meeting of the American Society of Clinical Oncology in Atlanta.

"This is the first attempt to make immunologic sense of the effects of IFNa2b on patients receiving this drug to prevent the recurrence of melanoma," said John Kirkwood, M.D., professor of medicine at the University of Pittsburgh and director of UPCI's Melanoma Center. "We found evidence that high-dose IFNa2b modulated the body's expression of cell markers called MHC Class II antigens on tumor tissues. These markers are necessary for the anti-tumor activity of one group of immune cells, or helper T cells. High-dose interferon also increased the response of a special set of immune cells, called natural killer cells, which may be more broadly active against melanoma cells."

Interferons are biological response modifiers produced naturally by the body to fight infections and tumors. IFNa2b is manufactured for use in cancer treatment studies, and can cause flu-like symptoms and depression in people receiving it.

The immunologic findings were made during a large study of high-dose IFNa2b, low-dose IFNa2b or observation for patients with surgically removed melanoma considered at high risk of recurrence. Results of this study have shown that recipients of a yearlong course of high-dose
'"/>

Contact: Lauren Ward
wardle@msx.upmc.edu
412-624-2607
University of Pittsburgh Medical Center
17-May-1999


Page: 1 2

Related medicine news :

1. Indiana University researchers closer to helping hearing-impaired using stem cells
2. Boston University team finds link between high cholesterol and better cognitive performance
3. University seeks recruits for arthritis study
4. University of Manchester awarded 826k for brain science and mental health research
5. $4 million grant boosts University of Michigan campaign for a new childrens hospital
6. Lead in the environment causes violent crime, reports University of Pittsburgh researcher at AAAS
7. Next generation body scanner launched by the University of Manchester
8. University of Washington joins new Autism Treatment Network to provide better medical services
9. Binghamton University launches microelectronics research center
10. University of Manchester makes made-to-measure skin and bones a reality using inkjet printers
11. RelayHealth selected by Columbia University to link doctors and patients online

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2020)... , ... January 10, 2020 , ... ... has announced that it will be attending the HIMSS (Healthcare Information and Management ... , HIMSS is the can’t-miss health information and technology event of the year, ...
(Date:1/8/2020)... ... 2020 , ... Mirror Mirror Beauty Boutique was ... Memorial Readers’ Choice Awards. Located adjacent to Vitenas Cosmetic Surgery, the office ... reflects Mirror Mirror Beauty Boutique’s commitment to the hottest noninvasive trends that can ...
(Date:1/7/2020)... ... 07, 2020 , ... Midmark Corp., a leading provider of ... will significantly impact the point of care ecosystem, where the majority of today’s ... and patient is the most important aspect of the healthcare journey. Medical, dental ...
(Date:1/7/2020)... , ... January 07, 2020 , ... Iconic singer, choreographer ... and being one of the most successful female artists of all time, but also ... first Las Vegas residency and shared in interviews her secrets to making it through ...
(Date:1/7/2020)... , ... January 07, 2020 , ... R3 Stem Cell ... known as the R3 Annual Membership, is available 24/7 and includes all the stem ... first rate regenerative medicine training courses in person. For the online regenerative training courses, ...
Breaking Medicine News(10 mins):
(Date:1/5/2020)... ... January 04, 2020 , ... ... Device makers and software firms are fighting for leadership in both devices and ... 2020 research report, during the past few years, multiple health-related voice assistants ...
(Date:1/3/2020)... ... January 03, 2020 , ... ... to transform the health of their patients. Although many medical professionals are jumping ... not needed. Smart shoppers are finding this product online. , In Addition to ...
(Date:1/1/2020)... , ... January 01, 2020 , ... ... retail franchise, recently donated $25,000 to the Children’s Tumor Foundation through its philanthropic ... Tumor Foundation 2019 Charity Golf Tournament in Orlando, Florida on October 7, 2019. ...
Breaking Medicine Technology:
Cached News: